MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Keefe, B. R.
Right arrow Articles by Boyd, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Keefe, B. R.
Right arrow Articles by Boyd, M. R.

Vol. 58, Issue 5, 982-992, November 2000

Analysis of the Interaction between the HIV-Inactivating Protein Cyanovirin-N and Soluble Forms of the Envelope Glycoproteins gp120 and gp41

Barry R. O'Keefe, Shilpa R. Shenoy, Dong Xie, Wentao Zhang, Jeffrey M. Muschik, Michael J. Currens, Irwin Chaiken, and Michael R. Boyd

Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis (B.R.O., S.P.S., J.M.M., M.J.C., M.R.B) and Structural Biochemistry Program (D.X.), SAIC Frederick, Frederick Cancer Research and Development Center, Frederick, Maryland; and Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (W.Z., I.C.)

The novel virucidal protein cyanovirin-N (CV-N) binds with equally high affinity to soluble forms of either H9 cell-produced or recombinant glycosylated HIV-1 gp120 (sgp120) or gp160 (sgp160). Fluorescence polarization studies showed that CV-N is also capable of binding to the glycosylated ectodomain of the HIV-envelope protein gp41 (sgp41) (as well as SIV glycoprotein 32), albeit with considerably lower affinity than the sgp120/CV-N interaction. Pretreatment of CV-N with either sgp120 or sgp41 abrogated the neutralizing activity of CV-N against intact, infectious HIV-1 virions. Isothermal calorimetry and optical biosensor binding studies showed that CV-N bound to recombinant sgp120 with a Kd value ranging from 2 to 45 nM and to sgp41 with a Kd value of 606 nM; furthermore, they indicated an approximate 5:1 stoichiometry for CV-N binding to sgp120 and a 1:1 stoichiometry for CV-N binding to sgp41. Circular dichroism studies additionally illuminated the binding of CV-N with both sgp120 and sgp41, providing the first direct evidence that conformational changes are a consequence of CV-N interactions with both HIV-1 envelope glycoproteins.

Copyright © 2000 by U.S. Government


This article has been cited by other articles:


Home page
 J. Virol.Home page
J. Balzarini, K. Van Laethem, D. Daelemans, S. Hatse, A. Bugatti, M. Rusnati, Y. Igarashi, T. Oki, and D. Schols
Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus
J. Virol., January 1, 2007; 81(1): 362 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
A. R. Geonnotti and D. F. Katz
Dynamics of HIV Neutralization by a Microbicide Formulation Layer: Biophysical Fundamentals and Transport Theory
Biophys. J., September 15, 2006; 91(6): 2121 - 2130.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Helle, C. Wychowski, N. Vu-Dac, K. R. Gustafson, C. Voisset, and J. Dubuisson
Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans
J. Biol. Chem., September 1, 2006; 281(35): 25177 - 25183.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Balzarini, K. Van Laethem, S. Hatse, M. Froeyen, W. Peumans, E. Van Damme, and D. Schols
Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120: A NEW THERAPEUTIC CONCEPT TO HIT THE ACHILLES HEEL OF HIV
J. Biol. Chem., December 9, 2005; 280(49): 41005 - 41014.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Mori, B. R. O'Keefe, R. C. Sowder II, S. Bringans, R. Gardella, S. Berg, P. Cochran, J. A. Turpin, R. W. Buckheit Jr., J. B. McMahon, et al.
Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.
J. Biol. Chem., March 11, 2005; 280(10): 9345 - 9353.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Balzarini, K. Van Laethem, S. Hatse, K. Vermeire, E. De Clercq, W. Peumans, E. Van Damme, A.-M. Vandamme, A. Bohlmstedt, and D. Schols
Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins
J. Virol., October 1, 2004; 78(19): 10617 - 10627.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
B. R. O'Keefe, D. F. Smee, J. A. Turpin, C. J. Saucedo, K. R. Gustafson, T. Mori, D. Blakeslee, R. Buckheit, and M. R. Boyd
Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2518 - 2525.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. A. Calarese, C. N. Scanlan, M. B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M. R. Wormald, R. L. Stanfield, K. H. Roux, et al.
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Science, June 27, 2003; 300(5628): 2065 - 2071.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. W.-P. Hong, K. B. Flummerfelt, A. de Parseval, K. Gurney, J. H. Elder, and B. Lee
Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells Is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120-DC-SIGN Binding
J. Virol., November 13, 2002; 76(24): 12855 - 12865.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Botos, B. R. O'Keefe, S. R. Shenoy, L. K. Cartner, D. M. Ratner, P. H. Seeberger, M. R. Boyd, and A. Wlodawer
Structures of the Complexes of a Potent Anti-HIV Protein Cyanovirin-N and High Mannose Oligosaccharides
J. Biol. Chem., September 6, 2002; 277(37): 34336 - 34342.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
J. A. Beutler, J. B. McMahon, T. R. Johnson, B. R. O'Keefe, R. A. Buzzell, D. Robbins, R. Gardella, J. Wilson, and M. R. Boyd
High Throughput Screening for Cyanovirin-N Mimetics Binding to HIV-1 gp4l
J Biomol Screen, April 1, 2002; 7(2): 105 - 110.
[Abstract] [PDF]

Home page
 Mol. Pharmacol.Home page
A. J. Bolmstedt, B. R. O'Keefe, S. R. Shenoy, J. B. McMahon, and M. R. Boyd
Cyanovirin-N Defines a New Class of Antiviral Agent Targeting N-Linked, High-Mannose Glycans in an Oligosaccharide-Specific Manner
Mol. Pharmacol., April 16, 2001; 59(5): 949 - 954.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. R. Shenoy, B. R. O'Keefe, A. J. Bolmstedt, L. K. Cartner, and M. R. Boyd
Selective Interactions of the Human Immunodeficiency Virus-Inactivating Protein Cyanovirin-N with High-Mannose Oligosaccharides on gp120 and Other Glycoproteins
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 704 - 710.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics